NextGen Healthcare Receives Surescripts White Coat of Quality Award
Company Honored for Third Time; Recognition Reaffirms its Dedication
to E-prescribing Quality
HORSHAM, Pa.--(BUSINESS WIRE)--
NextGen
Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality
Systems, Inc. (NASDAQ:QSII) and a leading provider of healthcare
information systems and connectivity solutions, announced today it is a
recipient of the Surescripts White Coat of Quality Award, marking its
third time earning this prestigious honor. The White Coat of Quality
Award is Surescripts' highest recognition for software providers that
uphold strict standards for clinical quality and best practices in
e-prescribing.
Established in 2010 as part of Surescripts' Quality Management Program,
the annual White Coat of Quality Award provides a systematic approach to
e-prescription quality. Organizations that follow the program's rigorous
guidelines can mitigate inaccurate, incomplete, or inconsistent
e-prescriptions, issues that can result in unintended consequences and
costly workflow interruptions to prescribers and pharmacists.
Recipients of the awards are evaluated on the following key requirements:
-
Senior leadership commitment to a goal of zero electronic prescription
content errors;
-
Measurement and reporting of e-prescription content error levels;
-
Implementation of software updates to reduce e-prescription content
error levels; and
-
Communication and training for end-users on how to better utilize
their e-prescribing system to reduce errors.
"As a three-time recipient of the Surescripts White Coat of Quality
Award, NextGen Healthcare's dedication to producing quality improvements
in e-prescribing is one to be mirrored by others in the industry," said
Ajit Dhavle, Pharm.D. MBA, director of quality management, Surescripts.
"We are pleased to recognize all those committed to implementing our
proven e-prescribing best practices and who worked hard to earn the
White Coat of Quality distinction."
"As we as a healthcare community continue to strive for excellence, the
quality and safety of the care patients are receiving is improving,"
said Dr. Sarah Corley, chief medical officer for NextGen Healthcare.
"Receiving the White Coat of Quality Award again underscores our
commitment to not only applying best practices to the use of
e-prescribing technology, but also to continuous quality improvement and
training of prescribers. Working closely with Surescripts, we are
committed to continuing to improve the quality, efficiency, and accuracy
of the e-prescribing experience."
About Surescripts
Surescripts is a nationwide health information network that connects,
exchanges, and activates health information between pharmacies, payers,
pharmacy benefit managers, physicians, hospitals, health information
exchanges and health technology firms. By providing information for
routine, recurring and emergency care, Surescripts is committed to
saving lives, improving efficiency and reducing the cost of health care
for all. For more information, go to www.surescripts.com
and follow us at twitter.com/surescripts.
About NextGen Healthcare
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary
of Quality Systems, Inc., provides integrated clinical, connectivity and
financial solutions, including revenue cycle management services for
ambulatory, inpatient and dental provider organizations. For more
information, please visit www.nextgen.com
and www.qsii.com.
Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen,
Facebook at http://www.facebook.com/NextGenHealthcare
or LinkedIn at http://www.linkedin.com/company/nextgen-healthcare-information-systems.
Certain statements in this news release are forward-looking
statements within the meaning of the federal securities laws, including
but not limited to those statements made by Dr. Sarah Corley related to
future collaboration with Surescripts, the Company's future products and
offerings, and developments and trends in the healthcare industry. These
statements are based on current expectations of future events. If
underlying assumptions prove inaccurate or unknown risks or
uncertainties materialize, actual results could vary materially from the
Company's expectations and projections. Factors that could cause
the anticipated results to differ from those described in the
forward-looking statements include the possibility that the products of
Cerner or the Company will not achieve or sustain market acceptance; the
impact of incentive payments under The American Recovery and
Reinvestment Act on sales and the ability of the Company to meet
continued certification requirements; the development by competitors of
new or superior technologies; the timing, cost and success or failure of
new product and service introductions, development and product upgrade
releases; undetected errors or bugs in our software; changing economic,
political or regulatory influences in the healthcare industry;
availability of third-party products and components; competitive
pressures including product offerings, pricing and promotional
activities; the Company's ability or inability to attract and retain
qualified personnel; possible regulation of the Company's software by
the U.S. Food and Drug Administration; and general economic conditions.
Additional risks and uncertainties are set forth in the Company's
public filings with the U.S. Securities and Exchange Commission,
including the discussion under the heading "Risk Factors" in the
Company's most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q. The Company expressly disclaims
any intent or obligation to update these forward-looking statements
except as required by law.
© 2014 Quality Systems, Inc., Irvine, CA 92612
® marks
owned by Quality Systems, Inc.
NextGen Healthcare
Michelle Rovner, 215-657-7010
[email protected]
Source: NextGen Healthcare
News Provided by Acquire Media
Close window | Back to top
